Astrana Health (NASDAQ:ASTH) Releases FY 2024 Earnings Guidance

Astrana Health (NASDAQ:ASTH) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 1.280-1.520 for the period, compared to the consensus EPS estimate of 1.510. The company issued revenue guidance of $1.7 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ASTH shares. Truist Financial lifted their price objective on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a research note on Friday, March 1st. Jefferies Financial Group assumed coverage on Astrana Health in a research report on Monday, February 26th. They set a buy rating and a $50.00 price target for the company.

Astrana Health Price Performance

ASTH stock opened at $37.93 on Wednesday. The business has a 50 day moving average of $40.36. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. The stock has a market cap of $2.13 billion, a PE ratio of 28.74, a PEG ratio of 1.20 and a beta of 1.12. Astrana Health has a one year low of $28.86 and a one year high of $45.71.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. During the same period in the prior year, the company earned $0.42 EPS. The firm’s revenue was up 19.9% compared to the same quarter last year. On average, research analysts expect that Astrana Health will post 1.65 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.